Synmosa Biopharma Corporation (4114.TWO)

TWD 33.45

(0.0%)

Net Debt Summary of Synmosa Biopharma Corporation

  • Synmosa Biopharma Corporation's latest annual net debt in 2023 was 1.52 Billion TWD , down -33.39% from previous year.
  • Synmosa Biopharma Corporation's latest quarterly net debt in 2024 Q2 was 1.27 Billion TWD , down -19.28% from previous quarter.
  • Synmosa Biopharma Corporation reported annual net debt of 2.28 Billion TWD in 2022, down -12.0% from previous year.
  • Synmosa Biopharma Corporation reported annual net debt of 2.59 Billion TWD in 2021, down -15.29% from previous year.
  • Synmosa Biopharma Corporation reported quarterly net debt of 1.58 Billion TWD for 2024 Q1, up 4.0% from previous quarter.
  • Synmosa Biopharma Corporation reported quarterly net debt of 1.65 Billion TWD for 2023 Q3, up 26.7% from previous quarter.

Annual Net Debt Chart of Synmosa Biopharma Corporation (2023 - 2019)

Historical Annual Net Debt of Synmosa Biopharma Corporation (2023 - 2019)

Year Net Debt Net Debt Growth
2023 1.52 Billion TWD -33.39%
2022 2.28 Billion TWD -12.0%
2021 2.59 Billion TWD -15.29%
2020 3.06 Billion TWD 11.61%
2019 2.74 Billion TWD 0.0%

Peer Net Debt Comparison of Synmosa Biopharma Corporation

Name Net Debt Net Debt Difference
Allied Biotech Corporation 178.11 Million TWD -754.121%
GeneFerm Biotechnology Co., Ltd. 31.92 Million TWD -4665.082%
Easywell Biomedicals, Inc. 123.43 Million TWD -1132.451%
TTY Biopharm Company Limited -705.97 Million TWD 315.489%
Orient EuroPharma Co., Ltd. 3.1 Billion TWD 51.026%
Center Laboratories, Inc. 3.91 Billion TWD 61.182%
Tien Liang BioTech Co., Ltd. -57.55 Million TWD 2743.165%
Orient Pharma Co., Ltd. 633.6 Million TWD -140.101%
InnoPharmax Inc. -17.85 Million TWD 8618.871%
Johnson Chemical Pharmaceutical Works Co., Ltd. -926.77 Million TWD 264.149%
Excelsior Biopharma Inc. -212.51 Million TWD 815.862%
DV Biomed Co., Ltd. 160.7 Million TWD -846.671%
Foresee Pharmaceuticals Co., Ltd. -781.42 Million TWD 294.684%
Handa Pharmaceuticals, Inc. -653.8 Million TWD 332.684%
UniPharma Co., Ltd. -68.36 Million TWD 2325.196%
Anxo Pharmaceutical Co., Ltd. 492.4 Million TWD -208.952%
Alar Pharmaceuticals Inc. -738.05 Million TWD 306.123%
Winston Medical Supply Co., Ltd. -191.81 Million TWD 893.129%
Mercury Biopharmaceutical Corporation -1.94 Million TWD 78315.938%
Bioray Biotech Co., Ltd -27.23 Million TWD 5686.442%
TSH Biopharm Corporation Limited -568.74 Million TWD 367.485%